# ALNYLAM PHARMACEUTICALS, INC. (ALNY) FY2026 Q2 P&L / Income Statement

- Company: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0001178670-26-000062
- Page: https://plicit.ai/financials/alny/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/alny-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-04-01 through 2026-06-30. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,290,948,000 US dollars
- **Cost of goods sold**: 298,261,000 US dollars
- **Gross profit (calculated)**: 992,687,000 US dollars
- **Operating expenses (calculated)**: 761,246,000 US dollars
- **Income (loss) from operations**: 231,441,000 US dollars
- **Total other expense, net**: negative 53,635,000 US dollars
- **Income (loss) before income taxes**: 177,806,000 US dollars
- **Provision for income taxes**: 13,312,000 US dollars
- **Net income (loss)**: 164,494,000 US dollars
- **Net revenues from collaborations**: 47,165,000 US dollars
- **Royalty revenue**: 71,674,000 US dollars
- **Amvuttra - Rest of World**: 83,673,000 US dollars
- **Amvuttra - UNITED STATES**: 809,079,000 US dollars
- **Amvuttra - Europe**: 119,010,000 US dollars
- **GIVLAARI - Rest of World**: 7,441,000 US dollars
- **GIVLAARI - UNITED STATES**: 58,000,000 US dollars
- **GIVLAARI - Europe**: 24,323,000 US dollars
- **ONPATTRO - Rest of World**: 3,090,000 US dollars
- **ONPATTRO - UNITED STATES**: 9,863,000 US dollars
- **ONPATTRO - Europe**: 5,508,000 US dollars
- **OXLUMO - Rest of World**: 10,899,000 US dollars
- **OXLUMO - UNITED STATES**: 18,545,000 US dollars
- **OXLUMO - Europe**: 22,678,000 US dollars
- **Cost of collaborations and royalties**: 190,000 US dollars
- **Research and development**: 413,134,000 US dollars
- **Selling, general and administrative**: 347,922,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Counterparty Name

- Page: https://plicit.ai/financials/alny/fy2026-q2-income-statement/revenue-by-counterparty-name
- Chart image: https://plicit.ai/charts/alny-fy2026-q2-revenue-by-counterparty-name-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Counterparty Name. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,290,948,000 US dollars
- **Cost of goods sold**: 298,261,000 US dollars
- **Gross profit (calculated)**: 992,687,000 US dollars
- **Operating expenses (calculated)**: 761,246,000 US dollars
- **Income (loss) from operations**: 231,441,000 US dollars
- **Total other expense, net**: negative 53,635,000 US dollars
- **Income (loss) before income taxes**: 177,806,000 US dollars
- **Provision for income taxes**: 13,312,000 US dollars
- **Net income (loss)**: 164,494,000 US dollars
- **Other**: 257,000 US dollars
- **Regeneron Pharmaceuticals**: 5,020,000 US dollars
- **Roche**: 41,888,000 US dollars
- **Net product revenues**: 1,172,109,000 US dollars
- **Royalty revenue**: 71,674,000 US dollars
- **Cost of collaborations and royalties**: 190,000 US dollars
- **Research and development**: 413,134,000 US dollars
- **Selling, general and administrative**: 347,922,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (6 categories)

- Page: https://plicit.ai/financials/alny/fy2026-q2-income-statement/revenue-by-product-and-service-6-categories
- Chart image: https://plicit.ai/charts/alny-fy2026-q2-revenue-by-product-and-service-6-categories-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (6 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,290,948,000 US dollars
- **Cost of goods sold**: 298,261,000 US dollars
- **Gross profit (calculated)**: 992,687,000 US dollars
- **Operating expenses (calculated)**: 761,246,000 US dollars
- **Income (loss) from operations**: 231,441,000 US dollars
- **Total other expense, net**: negative 53,635,000 US dollars
- **Income (loss) before income taxes**: 177,806,000 US dollars
- **Provision for income taxes**: 13,312,000 US dollars
- **Net income (loss)**: 164,494,000 US dollars
- **GIVLAARI**: 89,764,000 US dollars
- **OXLUMO**: 52,122,000 US dollars
- **Amvuttra**: 1,011,762,000 US dollars
- **ONPATTRO**: 18,461,000 US dollars
- **Net revenues from collaborations**: 47,165,000 US dollars
- **Royalty revenue**: 71,674,000 US dollars
- **Cost of collaborations and royalties**: 190,000 US dollars
- **Research and development**: 413,134,000 US dollars
- **Selling, general and administrative**: 347,922,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (3 categories)

- Page: https://plicit.ai/financials/alny/fy2026-q2-income-statement/revenue-by-product-and-service-3-categories
- Chart image: https://plicit.ai/charts/alny-fy2026-q2-revenue-by-product-and-service-3-categories-sankey.png

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,290,948,000 US dollars
- **Cost of goods sold**: 298,261,000 US dollars
- **Gross profit (calculated)**: 992,687,000 US dollars
- **Operating expenses (calculated)**: 761,246,000 US dollars
- **Income (loss) from operations**: 231,441,000 US dollars
- **Total other expense, net**: negative 53,635,000 US dollars
- **Income (loss) before income taxes**: 177,806,000 US dollars
- **Provision for income taxes**: 13,312,000 US dollars
- **Net income (loss)**: 164,494,000 US dollars
- **Net product revenues**: 1,172,109,000 US dollars
- **Net revenues from collaborations**: 47,165,000 US dollars
- **Royalty revenue**: 71,674,000 US dollars
- **Cost of collaborations and royalties**: 190,000 US dollars
- **Research and development**: 413,134,000 US dollars
- **Selling, general and administrative**: 347,922,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.